Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice.

The intestinal microbiota has been associated with the occurrence and development of mastitis, which is one of the most serious diseases of lactating women and female animals, but the underlying mechanism has not yet been elucidated. Aryl hydrocarbon receptor (AhR) activation by microbiota tryptopha...

Full description

Bibliographic Details
Main Authors: Caijun Zhao, Xiaoyu Hu, Lijuan Bao, Keyi Wu, Lianjun Feng, Min Qiu, Haoyang Hao, Yunhe Fu, Naisheng Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-07-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1009774
_version_ 1819241169696063488
author Caijun Zhao
Xiaoyu Hu
Lijuan Bao
Keyi Wu
Lianjun Feng
Min Qiu
Haoyang Hao
Yunhe Fu
Naisheng Zhang
author_facet Caijun Zhao
Xiaoyu Hu
Lijuan Bao
Keyi Wu
Lianjun Feng
Min Qiu
Haoyang Hao
Yunhe Fu
Naisheng Zhang
author_sort Caijun Zhao
collection DOAJ
description The intestinal microbiota has been associated with the occurrence and development of mastitis, which is one of the most serious diseases of lactating women and female animals, but the underlying mechanism has not yet been elucidated. Aryl hydrocarbon receptor (AhR) activation by microbiota tryptophan metabolism-derived ligands is involved in maintaining host homeostasis and resisting diseases. We investigated whether AhR activation by microbiota-metabolic ligands could influence mastitis development in mice. In this study, we found that AhR activation using Ficz ameliorated mastitis symptoms, which were related to limiting NF-κB activation and enhancing barrier function. Impaired AhR activation by disturbing the intestinal microbiota initiated mastitis, and processed Escherichia coli (E. coli)-induced mastitis in mice. Supplementation with dietary tryptophan attenuated the mastitis, but attenuation was inhibited by the intestinal microbiota abrogation, while administering tryptophan metabolites including IAld and indole but not IPA, rescued the tryptophan effects in dysbiotic mice. Supplementation with a Lactobacillus reuteri (L. reuteri) strain with the capacity to produce AhR ligands also improved E. coli-induced mastitis in an AhR-dependent manner. These findings provide evidence for novel therapeutic strategies for treating mastitis, and support the role of metabolites derived from the intestinal microbiota in improving distal disease.
first_indexed 2024-12-23T14:19:38Z
format Article
id doaj.art-cd089d8873d240e89a8956afa8cbbfcc
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-23T14:19:38Z
publishDate 2021-07-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-cd089d8873d240e89a8956afa8cbbfcc2022-12-21T17:43:50ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742021-07-01177e100977410.1371/journal.ppat.1009774Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice.Caijun ZhaoXiaoyu HuLijuan BaoKeyi WuLianjun FengMin QiuHaoyang HaoYunhe FuNaisheng ZhangThe intestinal microbiota has been associated with the occurrence and development of mastitis, which is one of the most serious diseases of lactating women and female animals, but the underlying mechanism has not yet been elucidated. Aryl hydrocarbon receptor (AhR) activation by microbiota tryptophan metabolism-derived ligands is involved in maintaining host homeostasis and resisting diseases. We investigated whether AhR activation by microbiota-metabolic ligands could influence mastitis development in mice. In this study, we found that AhR activation using Ficz ameliorated mastitis symptoms, which were related to limiting NF-κB activation and enhancing barrier function. Impaired AhR activation by disturbing the intestinal microbiota initiated mastitis, and processed Escherichia coli (E. coli)-induced mastitis in mice. Supplementation with dietary tryptophan attenuated the mastitis, but attenuation was inhibited by the intestinal microbiota abrogation, while administering tryptophan metabolites including IAld and indole but not IPA, rescued the tryptophan effects in dysbiotic mice. Supplementation with a Lactobacillus reuteri (L. reuteri) strain with the capacity to produce AhR ligands also improved E. coli-induced mastitis in an AhR-dependent manner. These findings provide evidence for novel therapeutic strategies for treating mastitis, and support the role of metabolites derived from the intestinal microbiota in improving distal disease.https://doi.org/10.1371/journal.ppat.1009774
spellingShingle Caijun Zhao
Xiaoyu Hu
Lijuan Bao
Keyi Wu
Lianjun Feng
Min Qiu
Haoyang Hao
Yunhe Fu
Naisheng Zhang
Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice.
PLoS Pathogens
title Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice.
title_full Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice.
title_fullStr Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice.
title_full_unstemmed Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice.
title_short Aryl hydrocarbon receptor activation by Lactobacillus reuteri tryptophan metabolism alleviates Escherichia coli-induced mastitis in mice.
title_sort aryl hydrocarbon receptor activation by lactobacillus reuteri tryptophan metabolism alleviates escherichia coli induced mastitis in mice
url https://doi.org/10.1371/journal.ppat.1009774
work_keys_str_mv AT caijunzhao arylhydrocarbonreceptoractivationbylactobacillusreuteritryptophanmetabolismalleviatesescherichiacoliinducedmastitisinmice
AT xiaoyuhu arylhydrocarbonreceptoractivationbylactobacillusreuteritryptophanmetabolismalleviatesescherichiacoliinducedmastitisinmice
AT lijuanbao arylhydrocarbonreceptoractivationbylactobacillusreuteritryptophanmetabolismalleviatesescherichiacoliinducedmastitisinmice
AT keyiwu arylhydrocarbonreceptoractivationbylactobacillusreuteritryptophanmetabolismalleviatesescherichiacoliinducedmastitisinmice
AT lianjunfeng arylhydrocarbonreceptoractivationbylactobacillusreuteritryptophanmetabolismalleviatesescherichiacoliinducedmastitisinmice
AT minqiu arylhydrocarbonreceptoractivationbylactobacillusreuteritryptophanmetabolismalleviatesescherichiacoliinducedmastitisinmice
AT haoyanghao arylhydrocarbonreceptoractivationbylactobacillusreuteritryptophanmetabolismalleviatesescherichiacoliinducedmastitisinmice
AT yunhefu arylhydrocarbonreceptoractivationbylactobacillusreuteritryptophanmetabolismalleviatesescherichiacoliinducedmastitisinmice
AT naishengzhang arylhydrocarbonreceptoractivationbylactobacillusreuteritryptophanmetabolismalleviatesescherichiacoliinducedmastitisinmice